AG
GMED icon

Algert Global’s Globus Medical GMED Stock Holding History

Algert Global’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
133,660
+6,740
+5% +$573K 0.13% 247
2026
Q1 		$10.9M Buy
126,920
+68,330
+117% +$6.13M 0.16% 184
2025
Q4 		$5.12M Buy
+58,590
New +$4.45M 0.08% 429
2025
Q2 		– Sell
-154,724
Closed -$11.3M – 1234
2025
Q1 		$11.3M Sell
154,724
-54,823
-26% -$4.53M 0.28% 72
2024
Q4 		$17.3M Buy
209,547
+88,314
+73% +$6.97M 0.41% 15
2024
Q3 		$8.67M Buy
121,233
+42,850
+55% +$3.02M 0.23% 106
2024
Q2 		$5.37M Sell
78,383
-36,030
-31% -$2.15M 0.18% 159
2024
Q1 		$6.14M Sell
114,413
-884
-0.8% -$47.5K 0.24% 111
2023
Q4 		$6.14M Buy
115,297
+82,447
+251% +$4.02M 0.25% 96
2023
Q3 		$1.63M Sell
32,850
-18,890
-37% -$1.06M 0.08% 433
2023
Q2 		$3.08M Buy
51,740
+28,510
+123% +$1.62M 0.13% 235
2023
Q1 		$1.32M Buy
+23,230
New +$1.49M 0.06% 516
2022
Q2 		– Sell
-39,680
Closed -$2.93M – 1278
2022
Q1 		$2.93M Buy
+39,680
New +$2.76M 0.19% 126
2021
Q4 		– Sell
-2,753
Closed -$211K – 1027
2021
Q3 		$211K Buy
+2,753
New +$221K 0.03% 890
2020
Q3 		– Sell
-5,220
Closed -$249K – 437
2020
Q2 		$249K Sell
5,220
-30,349
-85% -$1.46M 0.08% 299
2020
Q1 		$1.51M Buy
35,569
+2,741
+8% +$135K 0.64% 22
2019
Q4 		$1.93M Buy
32,828
+26,924
+456% +$1.46M 0.58% 54
2019
Q3 		$302K Buy
+5,904
New +$281K 0.11% 219

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Algert Global's GMED Position: Q2 2026 in Review

Algert Global increased its Globus Medical (GMED) stake by 5.3% in Q2 2026, buying an estimated $573K and bringing the position to 133,660 shares worth $10.6M. The position accounts for 0.13% of the portfolio, ranked #247.

Algert Global first reported a position in GMED in Q3 2019 and has held it in 18 quarters since. The position peaked at $17.3M in Q4 2024. 598 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Algert Global held 133,660 shares of Globus Medical worth $10.6M as of Q2 2026.
  • Algert Global bought 6,740 Globus Medical shares in Q2 2026, an estimated $573K.
  • Globus Medical made up 0.13% of Algert Global's portfolio in Q2 2026, its #247 holding.
  • Algert Global first reported a position in Globus Medical in Q3 2019 and has held it in 18 quarters since.
  • Algert Global's Globus Medical position peaked at $17.3M in Q4 2024.
  • 598 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.